A new FDA-cleared test for latent M. tuberculosis (TB) infection, Quantiferon-TB (QF), measures TB-induced secretion of interferon-gamma (IFN) by peripheral blood cells in vitro. We questioned whether TST responses could be enhanced by TST placement in individuals that were ultimately TST-negative by two-step testing. We analyzed 9 subjects with past medical histories of TST reactivity who were subsequently negative on two-step TST testing. Blood was obtained for QF at baseline and at the time of second TST. Using recommended strategies for interpretation, no QF tests were positive either at baseline or on repeat testing. Three initial QF and 2 repeat QF tests were scored as negative due to a requirement that IFN secretion stimulated by M. avium antigen be no more than 10% greater than TB antigen-induced IFN secretion even though other requirements for test positivity were achieved. Mean levels of IFN secretion to TB antigen expressed either as absolute units or as percentage of mitogen-induced secretion did not significantly increase on repeat testing. In this population, placement of a TST did not enhance subsequent QF responses. The sensitivity of QF for detecting immunity to TB may be decreased by current guidelines for interpretation of reactivity to M. avium antigen.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.